Ovarian Carcinoma Therapy with Monoclonal Antibodies

This publication has 14 references indexed in Scilit:

• Two-step tumour targetting in ovarian cancer patients using biotinylated monoclonal antibodies and radioactive streptavidin
  European Journal of Nuclear Medicine and Molecular Imaging, 1992
• Human Antibody Response to the Intravenous and Intraperitoneal Administration of the F(ab')2 Fragment of the OC125 Murine Monoclonal Antibody
  Journal of Immunotherapy, 1992
• Prognostic significance of her‐2/neu expression in breast cancer and its relationship to other prognostic factors
  International Journal of Cancer, 1991
• Radioimmunoscintigraphy of ovarian cancer with the MOv18 monoclonal antibody
  European Journal of Cancer and Clinical Oncology, 1991
• Use of combination of monoclonal antibodies directed against three distinct epitopes of a tumor‐associated antigen: Analysis of cell binding and internalization
  International Journal of Cancer, 1991
• Selection of monoclonal antibodies which induce internalization and phosphorylation of P185^HER2 and growth inhibition of cells with HER2/neu gene amplification
  International Journal of Cancer, 1991
• Man-made antibodies
  Nature, 1991
• The Ca-MOv18 molecule, a cell-surface marker of human ovarian carcinomas, is anchored to the cell membrane by phosphatidylinositol
  Biochemical and Biophysical Research Communications, 1990
• Characterization of human ovarian carcinoma‐associated antigens defined by novel monoclonal antibodies with tumor‐restricted specificity
  International Journal of Cancer, 1987
• Specific targeting of cytotoxic T cells by anti-T3 linked to anti-target cell antibody
  Nature, 1985